Jagsonpal Pharmaceuticals Ltd. - Research Center
507789 JAGSNPHARM Group (B) BSE data
Add to watchlist
| Results |
Annual
|
| Statement | |
| More |
Annual results in brief
(Rs crore)
| Mar ' 24 | Mar ' 23 | Mar ' 22 | Mar ' 21 | Mar ' 20 | |
|---|---|---|---|---|---|
| Sales | 208.70 | 236.71 | 226.10 | 187.95 | 158.57 |
| Operating profit | 23.07 | 34.15 | 25.79 | 19.08 | 8.53 |
| Interest | 0.81 | 0.41 | 0.29 | 0.51 | 0.51 |
| Gross profit | 31.53 | 39.47 | 28.85 | 22.96 | 10.54 |
| EPS (Rs) | 8.50 | 10.20 | 7.48 | 6.52 | 3.00 |
Annual
results in details
| Mar ' 24 | Mar ' 23 | Mar ' 22 | Mar ' 21 | Mar ' 20 | |
|---|---|---|---|---|---|
| Other income | 9.28 | 5.73 | 3.34 | 4.39 | 2.53 |
| Stock adjustment | 3.90 | 4.30 | 5.61 | 5.28 | 1.25 |
| Raw material | 22.10 | 31.21 | 40.42 | 38.63 | 36.79 |
| Power and fuel | - | - | - | - | - |
| Employee expenses | 48.49 | 56.41 | 57.68 | 53.98 | 50.37 |
| Excise | - | - | - | - | - |
| Admin and selling expenses | - | - | - | - | - |
| Research and development expenses | - | - | - | - | - |
| Expenses capitalised | - | - | - | - | - |
| Other expenses | 111.15 | 110.63 | 96.60 | 70.97 | 61.63 |
| Provisions made | - | - | - | - | - |
| Depreciation | 1.66 | 1.21 | 1.53 | 1.09 | 1.13 |
| Taxation | 7.41 | 8.09 | 7.73 | 4.81 | 1.54 |
| Net profit / loss | 22.46 | 26.72 | 19.59 | 17.06 | 7.87 |
| Extra ordinary item | - | -3.46 | - | - | - |
| Prior year adjustments | - | - | - | - | - |
| Equity capital | 13.22 | 13.10 | 13.10 | 13.09 | 13.10 |
| Equity dividend rate | - | - | - | - | - |
| Agg.of non-prom. shares (Lacs) | - | - | - | - | - |
| Agg.of non promotoholding (%) | - | - | - | - | - |
| OPM (%) | 11.05 | 14.43 | 11.41 | 10.15 | 5.38 |
| GPM (%) | 14.47 | 16.28 | 12.57 | 11.94 | 6.55 |
| NPM (%) | 10.31 | 11.02 | 8.54 | 8.87 | 4.89 |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis